Allmed Medical Products Co.,Ltd (SHE:002950)
China
· Delayed Price · Currency is CNY 8.48
-0.22 (-2.53%)
Jun 18, 2025, 3:04 PM CST
SHE:002950 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 17, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Market Capitalization | 5,247 | 5,419 | 6,003 | 7,758 | 10,354 | 12,862 | Upgrade
|
Market Cap Growth | 15.27% | -9.73% | -22.61% | -25.08% | -19.50% | 46.12% | Upgrade
|
Enterprise Value | 5,105 | 5,590 | 6,190 | 8,709 | 11,541 | 13,139 | Upgrade
|
Last Close Price | 8.42 | 8.73 | 9.44 | 12.13 | 15.92 | 18.91 | Upgrade
|
PE Ratio | 14.67 | 14.70 | 54.38 | 19.07 | 24.01 | 11.11 | Upgrade
|
Forward PE | - | 10.45 | 10.45 | 10.45 | 10.45 | 11.61 | Upgrade
|
PS Ratio | 1.57 | 1.63 | 2.18 | 1.84 | 3.54 | 3.35 | Upgrade
|
PB Ratio | 1.49 | 1.57 | 1.87 | 2.48 | 3.76 | 4.40 | Upgrade
|
P/TBV Ratio | 1.62 | 1.72 | 2.08 | 2.78 | 4.15 | 4.78 | Upgrade
|
P/FCF Ratio | 9.31 | 9.77 | 43.81 | 10.32 | 123.03 | 10.78 | Upgrade
|
P/OCF Ratio | 7.38 | 7.62 | 14.18 | 6.75 | 27.62 | 8.95 | Upgrade
|
EV/Sales Ratio | 1.53 | 1.68 | 2.25 | 2.07 | 3.95 | 3.43 | Upgrade
|
EV/EBITDA Ratio | 7.92 | 8.45 | 15.30 | 8.64 | 21.66 | 9.79 | Upgrade
|
EV/EBIT Ratio | 12.41 | 12.89 | 34.26 | 10.67 | 29.77 | 10.95 | Upgrade
|
EV/FCF Ratio | 9.06 | 10.08 | 45.18 | 11.59 | 137.13 | 11.01 | Upgrade
|
Debt / Equity Ratio | 0.21 | 0.19 | 0.30 | 0.30 | 0.47 | 0.41 | Upgrade
|
Debt / EBITDA Ratio | 1.15 | 0.99 | 2.36 | 0.93 | 2.41 | 0.88 | Upgrade
|
Debt / FCF Ratio | 1.31 | 1.19 | 7.01 | 1.25 | 15.32 | 0.99 | Upgrade
|
Asset Turnover | 0.64 | 0.66 | 0.51 | 0.78 | 0.59 | 0.96 | Upgrade
|
Inventory Turnover | 3.65 | 3.63 | 2.65 | 3.26 | 2.64 | 3.14 | Upgrade
|
Quick Ratio | 1.21 | 1.11 | 0.72 | 0.66 | 0.78 | 1.29 | Upgrade
|
Current Ratio | 1.82 | 1.74 | 1.34 | 1.16 | 1.37 | 1.94 | Upgrade
|
Return on Equity (ROE) | 10.58% | 11.08% | 3.29% | 13.76% | 15.22% | 46.58% | Upgrade
|
Return on Assets (ROA) | 4.96% | 5.34% | 2.08% | 9.49% | 4.91% | 18.71% | Upgrade
|
Return on Capital (ROIC) | 6.06% | 6.55% | 2.74% | 12.58% | 5.95% | 22.21% | Upgrade
|
Return on Capital Employed (ROCE) | 10.10% | 11.00% | 4.80% | 22.20% | 11.50% | 35.40% | Upgrade
|
Earnings Yield | 6.89% | 6.80% | 1.84% | 5.24% | 4.17% | 9.00% | Upgrade
|
FCF Yield | 10.74% | 10.23% | 2.28% | 9.69% | 0.81% | 9.28% | Upgrade
|
Dividend Yield | 0.69% | 0.69% | 0.29% | 0.50% | 1.32% | 4.65% | Upgrade
|
Payout Ratio | 11.96% | 11.96% | 59.07% | 40.29% | 133.84% | 23.02% | Upgrade
|
Buyback Yield / Dilution | 1.34% | 1.33% | -0.02% | -0.17% | 0.05% | -2.81% | Upgrade
|
Total Shareholder Return | 2.03% | 2.01% | 0.26% | 0.33% | 1.37% | 1.85% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.